Clinical Trials
2 trialsNCT00420888 2015-07-22
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Active Biotech AB
Phase 2/3 Completed
NCT00330707 2011-03-04
Combined Use of BCG and Interferon Alpha in Bladder Cancer
National University Hospital, Singapore
Phase 2/3 Completed